Skip to main content
. 2020 Sep 23;106(1):108–119. doi: 10.1210/clinem/dgaa682

Table 3.

Correlation between change in key parameters and change in assays

Change in Oxyntomodulin Change in Follistatin
Spearman Correlation Coefficient
(95% CI)
P-value Spearman Correlation Coefficient
(95% CI)
P-value
Change in weight -0.21 (-0.41, 0.00) 0.05 0.29 (0.08, 0.47) 0.01
Change in waist circumference -0.21 (-0.41, 0.00) 0.05 0.26 (0.05, 0.45) 0.02
Change in antral follicle count 0.11 (-0.14, 0.34) 0.40 -0.36 (-0.55, -0.13) 0.003
Change in total ovarian volume 0.27 (0.03, 0.48) 0.03 -0.41 (-0.59, -0.19)  <0.001
Change in testosterone 0.17 (-0.05, 0.37) 0.12 -0.47 (-0.62, -0.29)  <0.001
Change in SHBG -0.21 (-0.40, 0.00) 0.05 0.48 (0.30, 0.63)  <0.001
Change in triglycerides -0.22 (-0.41, 0.00) 0.05 0.24 (0.03, 0.43) 0.03
Change in fasting glucose -0.07 (-0.28, 0.15) 0.53 0.15 (-0.06, 0.35) 0.17
Change in fasting insulin -0.17 (-0.37, 0.04) 0.12 0.31 (0.11, 0.50) 0.003
Change in 2-hour glucose -0.26 (-0.45, -0.05) 0.02 0.27 (0.06, 0.46) 0.01
Change in 2-hour insulin -0.35 (-0.53, -0.14) 0.001 0.21 (-0.01, 0.41) 0.06
Change in AUC glucose -0.38 (-0.57, -0.16) 0.001 0.40 (0.18, 0.59)  <0.001
Change in AUC insulin -0.32 (-0.52, -0.08) 0.01 0.06 (-0.18, 0.30) 0.63
Change in insulin sensitivity index 0.48 (0.27, 0.64)  <0.001 -0.36 (-0.55, -0.14) 0.002
Change in DXA total BMD -0.04 (-0.26, 0.19) 0.73 0.03 (-0.20, 0.25) 0.81
Change in DXA fat -0.17 (-0.38, 0.06) 0.15 0.29 (0.07, 0.48) 0.01
Change in DXA % fat -0.13 (-0.34, 0.10) 0.28 0.27 (0.05, 0.47) 0.02

Abbreviations: AUC, area under the curve; BMD, bone mineral density; CI, confidence intervals; DXA, dual energy x-ray absorptiometry; SHBG, sex hormone binding globulin.